Comparable disease progression for small pancreatic neuroendocrine tumors (≤2 cm) with or without surgery

Researchers compared the disease progression in patients with nonfunctional pancreatic neuroendocrine tumors (pnets) ≤2 cm who either underwent surgery or were observed. Out of the 52 patients, 75% had an operation while 25% were observed. Both groups had similar demographics and tumor characteristics. The observation group had a mean disease progression interval of 80.9 months, while the group that underwent surgery had a mean disease progression interval of 94.6 months. Overall, there was no significant difference in disease progression between the two groups.